Literature DB >> 26447101

A review in the treatment of oncologic emergencies.

Judy Pi1, Young Kang1, Michael Smith1, Marc Earl1, Zaven Norigian1, Ali McBride2.   

Abstract

AIM: Oncologic emergencies are often categorized as a group of metabolic abnormalities associated with the diagnosis of cancer or the initiation of chemotherapy for treatment. These syndromes often arise in the acute setting, demanding an accurate knowledge of the associated condition and current treatment. In this review, we evaluate five oncologic emergencies: tumor lysis syndrome, hypercalcemia, hyponatremia, spinal cord compression, and disseminated intravascular coagulation.
SUMMARY: Oncologic emergencies are often diverse in etiology and are often associated with the initiation of chemotherapy. Tumor lysis syndrome presents as severe electrolyte abnormalities that need to be addressed urgently, sometimes prior to initiation of chemotherapy. Hypercalcemia of malignancy is treated with aggressive rehydration, furosemide, and intravenous bisphosphonates. If a patient with cancer presents with normovolemic hyponatremia, syndrome of inappropriate antidiuretic hormone should be suspected. Malignant spinal cord compression happens when cancer cells grow in, or near to, the spine and press on the spinal cord and nerves. This causes swelling and a reduction in the blood supply to the spinal cord and nerve roots. Disseminated intravascular coagulation is characterized by systemic activation of blood coagulation, which results in generation and deposition of fibrin, leading to microvascular thrombi in various organs and contributing to multiple organ dysfunction syndrome.
CONCLUSION: Knowledge of oncology emergencies is critical to the understanding of these emergent syndromes in oncology patients. Each of these disease states requires careful evaluation of the patient's symptoms, monitoring parameters for conditions and supportive care measures and interventions.
© The Author(s) 2015.

Entities:  

Keywords:  Tumor lysis syndrome; disseminated intravascular coagulation; hypercalcemia; hyponatremia; oncologic emergencies; spinal cord compression

Mesh:

Year:  2015        PMID: 26447101     DOI: 10.1177/1078155215605661

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN: 1078-1552            Impact factor:   1.809


  4 in total

1.  Clinical characteristics and therapeutic outcomes of mediastinal neuroblastoma with intraspinal extension: a retrospective study.

Authors:  Jue Tang; Dan Zhang; Ying-Yi Xu; Xin-Ke Xu; Feng-Hua Wang; Jia-Hang Zeng; Jiang-Hua Liang; Wei Liu; Le Li
Journal:  Transl Pediatr       Date:  2021-04

2.  EMERALD: Emergency visit audit of patients treated under medical oncology in a tertiary cancer center: Logical steps to decrease the burden.

Authors:  Amit Joshi; Vijay M Patil; Vanita Noronha; Anant Ramaswamy; Sudeep Gupta; Atanu Bhattacharjee; Avinash Bonda; M V Chandrakanth; Vikas Ostwal; Navin Khattry; Shripad Banavali; Kumar Prabhash
Journal:  South Asian J Cancer       Date:  2017 Oct-Dec

3.  LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.

Authors:  Ji Liu; Rui Xu; Shi-Juan Mai; Yu-Shui Ma; Mei-Yin Zhang; Ping-Sheng Cao; Nuo-Qing Weng; Rui-Qi Wang; Di Cao; Wei Wei; Rong-Ping Guo; Yao-Jun Zhang; Li Xu; Min-Shan Chen; Hui-Zhong Zhang; Long Huang; Da Fu; Hui-Yun Wang
Journal:  Theranostics       Date:  2020-06-12       Impact factor: 11.556

Review 4.  Therapeutics for paediatric oncological emergencies.

Authors:  Karen Ka Yan Leung; Kam Lun Hon; Wun Fung Hui; Alexander Kc Leung; Chi Kong Li
Journal:  Drugs Context       Date:  2021-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.